Rejoni
Develops a hydrogel system to treat uterine health conditions and prevent scarring
$25MSeries A
Role not disclosedFV
FemHealth Ventures
Activity from announced rounds
Activity in this selectionsimplyhealth-ventures-98030ada
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $173M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionGT Medical Technologies
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
$100MSeries E
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosed